Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C

Gut Liver. 2021 May 15;15(3):327-328. doi: 10.5009/gnl210191.

Authors

Chang Hun Lee¹, In Hee Kim¹

Affiliation

¹ Department of Internal Medicine, Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents / adverse effects
Carcinoma, Hepatocellular* / drug therapy
Carcinoma, Hepatocellular* / epidemiology
Hepatitis C, Chronic* / complications
Hepatitis C, Chronic* / drug therapy
Humans
Liver Neoplasms* / drug therapy
Liver Neoplasms* / epidemiology
Neoplasm Recurrence, Local

Substances

Antiviral Agents